Diagnosing liver steatosis is an essential precaution for detecting hepatocirrhosis and liver cancer in the early stages. However, automatic diagnosis of liver steatosis from ultrasound (US) images remains challenging due to poor visual quality from various origins, such as speckle noise and blurring. In this paper, we propose a fully automated liver steatosis prediction model using three deep learning neural networks. As a result, liver steatosis can be automatically detected with high accuracy and precision. First, transfer learning is used for semantically segmenting the liver and kidney (L-K) on parasagittal US images, and then cropping the L-K area from the original US images. The second neural network also involves semantic segmentation by checking the presence of a ring that is typically located around the kidney and cropping of the L-K area from the original US images. These cropped L-K areas are inputted to the final neural network, SteatosisNet, in order to grade the severity of fatty liver disease. The experimental results demonstrate that the proposed model can predict fatty liver disease with the sensitivity of 99.78%, specificity of 100%, PPV of 100%, NPV of 99.83%, and diagnostic accuracy of 99.91%, which is comparable to the common results annotated by medical experts.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398227 | PMC |
http://dx.doi.org/10.3390/s21165304 | DOI Listing |
J Diabetes Metab Disord
June 2025
Gastroenterology and Liver Disease Research Center, Research Institute for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background And Aim: A healthy diet has been recommended for non-alcoholic fatty liver disease (NAFLD). We aim to investigate the associations of diet quality indices with the risk of developingmetabolic-associated fatty liver disease (MAFLD).
Methods: We conducted this nested case-control study by recruiting 968 cases with MAFLD and 964 controls from the participants of the baseline phase of the Sabzevar Persian Cohort Study (SPCS).
PNAS Nexus
January 2025
Faculty of Medicine and Dentistry, William Harvey Research Institute, Barts and The London, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom.
Metabolic dysfunction-associated steatotic liver disease (MASLD), hepatic fibrosis, and portal hypertension constitute an increasing public health problem due to the growing prevalence of obesity and diabetes. C-type natriuretic peptide (CNP) is an endogenous regulator of cardiovascular homeostasis, immune cell reactivity, and fibrotic disease. Thus, we investigated a role for CNP in the pathogenesis of MASLD.
View Article and Find Full Text PDFAntioxid Redox Signal
January 2025
Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent hepatic disorder worldwide. Arachidonic acid 15-lipoxygenase (ALOX15), an enzyme catalyzing the peroxidation of polyunsaturated fatty acids, plays a crucial role in various diseases. Here, we sought to investigate the involvement of ALOX15 in MASLD.
View Article and Find Full Text PDFAssay Drug Dev Technol
January 2025
Department of Basic Medical Science, Quanzhou Medical College, Quanzhou, China.
Diabetol Metab Syndr
January 2025
Department of Radiology, Shanghai Health and Medical Center, No. 67 Dajishan, Binhu District, Wuxi, 214065, China.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by the presence of at least one cardiovascular disease (CVD) risk factor, underscoring its potential to elevate CVD risk in affected individuals. However, evidence linking MASLD to subclinical coronary atherosclerosis remains scarce, and further investigations are necessary to elucidate the independent role of varying MASLD severities as a CVD risk factor.
Methods: This study analyzed 7,507 participants aged ≥ 40 who underwent comprehensive health evaluations at the Shanghai Health and Medical Center.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!